Subanaesthetic dose of Ketamine in attenuating ischemia reperfusion injury in adult living donor liver transplant.

The effect of subanaesthetic dose of Ketamine in attenuating ischemia reperfusion injury in adult living donor liver transplant. A randomised controlled study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201512001367808

Enrollment

Registered

2015-11-27

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Liver transplantation

Interventions

Ketamine

Control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - American Society of Anesthesiologists physical status class II - III. - MELD score between 15-20.

Exclusion criteria

Exclusion criteria: - Ketamine hypersensitivity . - Haemodynamic instability. - Preoperative acute bacterial infection.

Design outcomes

Primary

Measure	Time frame
Interlukein 6	—

Secondary

Measure	Time frame
SVR (dyne/second/centimeter-5)	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026